The Latest Research on CDK 4/6 Inhibitors
Three CDK 4/6 inhibitors palbociclib (Ibrance®), ribociclib (Kisqali®), and abemaciclib (Verzenio®) are FDA approved for treating people with hormone...
Read MorePatient-Reported Outcomes: Including the Patient Voice in MBC Research
Patient-reported outcomes are information reported during a clinical trial by a person with MBC without interpretation by a doctor or anyone else. Having people...
Read MoreClinical Trial Outcomes: What is Being Studied and How is it Measured?
One of the benefits of participating in a clinical trial is more frequent monitoring of you and your cancer. In addition to receiving the study drug(s) at a...
Read MoreWhich Foods, Supplements, and Drugs Should I Avoid During MBC Treatment?
The drugs you take to treat your MBC may interact with foods, dietary supplements, and other drugs. Talk to your doctor and pharmacist about whether you should...
Read MoreWhy You Should Consider Repeat Biopsies
Your cancer may change over time and when spreading to different locations in your body. These changes can be detected with a biopsy. The pathologist will examine...
Read MoreBiomarkers to Guide MBC Treatment Decisions: PIK3CA, BRCA1/BRCA2, and PD-L1/PD-1
A biomarker is a gene, protein, or molecule produced by the body or tumor in a person with cancer that tells a doctor something about the cancer cells. MBC...
Read MoreOncolytic Viruses: Using Viruses to Kill Cancer Cells
Oncolytic viruses are being studied in clinical trials as a new way of treating cancer. This type of treatment uses viruses to kill cancer cells, though the...
Read MoreLobular Breast Cancer Metastasis: Highlighting the Researchers
In our five-part series, we are highlighting researchers and physicians that study and treat breast cancer that has spread to common sites: brain, bones, liver,...
Read MoreWhat is Measurable Disease?
In clinical trials, a common eligibility requirement is measurable disease. This is because researchers are often required to measure the size of tumors to...
Read MoreSEARCH OUR SITE
for past articles or specific information.